BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 33905872)

  • 1. Multiple endocrine neoplasia type 1 (MEN-1) and neuroendocrine neoplasms (NENs).
    Effraimidis G; Knigge U; Rossing M; Oturai P; Rasmussen ÅK; Feldt-Rasmussen U
    Semin Cancer Biol; 2022 Feb; 79():141-162. PubMed ID: 33905872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inherited tumor syndromes of gastroenteropancreatic and thoracic neuroendocrine neoplasms].
    Couvelard A; Scoazec JY
    Ann Pathol; 2020 Apr; 40(2):120-133. PubMed ID: 32035641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New therapies for patients with multiple endocrine neoplasia type 1.
    Geslot A; Vialon M; Caron P; Grunenwald S; Vezzosi D
    Ann Endocrinol (Paris); 2021 Apr; 82(2):112-120. PubMed ID: 33839123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of clinical characteristics between sporadic gastrinoma and multiple endocrine neoplasia type 1-related gastrinoma].
    Guo Y; Chen LH; Liu M; Zhang YX; Zhang N; Chen J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):875-882. PubMed ID: 34674462
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of MEN1 mutations in sporadic enteropancreatic neuroendocrine tumors by analysis of paraffin-embedded tissue.
    Mailman MD; Muscarella P; Schirmer WJ; Ellison EC; O'Dorisio TM; Prior TW
    Clin Chem; 1999 Jan; 45(1):29-34. PubMed ID: 9895334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple Endocrine Neoplasia Type 1 and the Pancreas: Diagnosis and Treatment of Functioning and Non-Functioning Pancreatic and Duodenal Neuroendocrine Neoplasia within the MEN1 Syndrome - An International Consensus Statement.
    Niederle B; Selberherr A; Bartsch DK; Brandi ML; Doherty GM; Falconi M; Goudet P; Halfdanarson TR; Ito T; Jensen RT; Larghi A; Lee L; Öberg K; Pavel M; Perren A; Sadowski SM; Tonelli F; Triponez F; Valk GD; O'Toole D; Scott-Coombes D; Thakker RV; Thompson GB; Treglia G; Wiedenmann B
    Neuroendocrinology; 2021; 111(7):609-630. PubMed ID: 32971521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple endocrine neoplasia type 1.
    Marini F; Falchetti A; Del Monte F; Carbonell Sala S; Gozzini A; Luzi E; Brandi ML
    Orphanet J Rare Dis; 2006 Oct; 1():38. PubMed ID: 17014705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complicated Case Presentation: Management of Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1.
    Mulvey CK; Van Loon K; Bergsland EK; Masharani U; Nakakura EK
    Pancreas; 2017 Mar; 46(3):416-426. PubMed ID: 28187108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical drug studies in MEN1-related neuroendocrine neoplasms (MEN1-NENs).
    Grozinsky-Glasberg S; Lines KE; Avniel-Polak S; Bountra C; Thakker RV
    Endocr Relat Cancer; 2020 Sep; 27(9):R345-R355. PubMed ID: 32590358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone-releasing hormone-producing pancreatic neuroendocrine tumor in a multiple endocrine neoplasia type 1 family with an uncommon phenotype.
    Sala E; Ferrante E; Verrua E; Malchiodi E; Mantovani G; Filopanti M; Ferrero S; Pietrabissa A; Vanoli A; La Rosa S; Zatelli MC; Beck-Peccoz P; Verga U
    Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):858-62. PubMed ID: 23542451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic Neuroendocrine Neoplasms in Multiple Endocrine Neoplasia Type 1.
    Marini F; Giusti F; Tonelli F; Brandi ML
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges and controversies in management of pancreatic neuroendocrine tumours in patients with MEN1.
    Yates CJ; Newey PJ; Thakker RV
    Lancet Diabetes Endocrinol; 2015 Nov; 3(11):895-905. PubMed ID: 26165399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1: Some Clarity But Continued Controversy.
    Jensen RT; Norton JA
    Pancreas; 2017; 46(5):589-594. PubMed ID: 28426491
    [No Abstract]   [Full Text] [Related]  

  • 14. Update on the clinical management of multiple endocrine neoplasia type 1.
    Pieterman CRC; Valk GD
    Clin Endocrinol (Oxf); 2022 Oct; 97(4):409-423. PubMed ID: 35319130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical aspects of multiple endocrine neoplasia type 1.
    Al-Salameh A; Cadiot G; Calender A; Goudet P; Chanson P
    Nat Rev Endocrinol; 2021 Apr; 17(4):207-224. PubMed ID: 33564173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Various neuroendocrine tumors in a family with multiple endocrine neoplasia type 1].
    Sepp K; Valkusz Z
    Orv Hetil; 2013 Dec; 154(51):2037-42. PubMed ID: 24334135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MENIN-mediated regulation of gastrin gene expression and its role in gastrinoma development.
    Elvis-Offiah UB; Duan S; Merchant JL
    FASEB J; 2023 May; 37(5):e22913. PubMed ID: 37078545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and treatment of multiple endocrine neoplasia type 1 (MEN1).
    Gaztambide S; Vazquez F; Castaño L
    Minerva Endocrinol; 2013 Mar; 38(1):17-28. PubMed ID: 23435440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical genetics of neuroendocrine tumors].
    Karges W; Adler G
    Med Klin (Munich); 2003 Dec; 98(12):712-6. PubMed ID: 14685672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients.
    Marini F; Giusti F; Brandi ML
    Orphanet J Rare Dis; 2018 Nov; 13(1):205. PubMed ID: 30428914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.